Clinical and mutational profile in spinal muscular atrophy with respiratory distress (SMARD): defining novel phenotypes through hierarchical cluster analysis
Authors:
- 12 April 2007
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 28 (8) , 808-815
Abstract
Autosomal recessive spinal muscular atrophy with respiratory distress (SMARD) is a heterogeneous disorder. Mutations in the immunoglobulin µ‐binding protein gene (IGHMBP2) lead to SMARD1, but clinical criteria that delineate SMARD1 from other SMARD syndromes are not well established. Here we present a retrospective clinical and genetic study to determine the criteria that would predict the presence or absence of IGHMBP2 mutations. From 141 patients with respiratory distress and a spinal muscular atrophy phenotype we recorded the clinical features through a questionnaire and sequenced the entire coding region of IGHMBP2. In 47 (33%) patients we identified IGHMBP2 mutations, 14 of which were not described before. Clinical features and combinations thereof associated with the presence of IGHMBP2 mutations were discovered through hierarchical cluster analysis. This method detects common traits not evident at first sight by grouping items according to their similarity. The combination of “manifestation of respiratory failure between 6 weeks and 6 months” AND (“presence of diaphragmatic eventration” OR “preterm birth”) predicted the presence of IGHMBP2 mutations with 98% sensitivity and 92% specificity. Non‐SMARD1 patients fell into two different symptom clusters, mainly separated by the age at respiratory failure and the presence of multiple congenital contractures. The 14 novel IGHMBP2 mutations comprised missense, frameshift, splice‐site, and nonsense mutations. All missense mutations altered conserved residues within or adjacent to the putative DNA helicase domain. The c.1235+3A>G splice‐site mutation did not entirely suppress correct splicing and we found a residual wild‐type IGHMBP2 mRNA steady‐state level of 24.4±6.9%, which was, however, not sufficient to avert SMARD1 in this patient. Hum Mutat 28(8), 808–815, 2007.Keywords
This publication has 34 references indexed in Scilit:
- Escobar Syndrome Is a Prenatal Myasthenia Caused by Disruption of the Acetylcholine Receptor Fetal γ SubunitThe American Journal of Human Genetics, 2006
- Mutation of Gene in Spinal Muscular Atrophy Respiratory Distress Type IPediatric Neurology, 2006
- ‘Congenital peripheral neuropathy presenting as apnoea and respiratory insufficiency: spinal muscular atrophy with respiratory distress type 1 (SMARD1)’Developmental Medicine & Child Neurology, 2004
- Genomic rearrangements at the IGHMBP2 gene locus in two patients with SMARD1Human Genetics, 2004
- Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathyHuman Molecular Genetics, 2004
- Refined genetic mapping of autosomal recessive chronic distal spinal muscular atrophy to chromosome 11q13.3 and evidence of linkage disequilibrium in European familiesEuropean Journal of Human Genetics, 2004
- Detecting Polymorphisms and Mutations in Candidate GenesThe American Journal of Human Genetics, 2002
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Improved Splice Site Detection in GenieJournal of Computational Biology, 1997
- A new group of putative RNA helicasesTrends in Biochemical Sciences, 1992